Corresponding Authors’ information:
1. Salamanca University Hospital, Paseo de San Vicente, 58-182, 37007 Salamanca
2. University of Salamanca, Paseo de San Vicente, 58-182, 37007 Salamanca
3. Instituto de Investigación Biomédica de Salamanca (IBSAL) Paseo de San Vicente, 58-182, 37007 Salamanca
4. Galvanize Therapeutics, Inc. 1531 Industrial Rd. San Carlos, CA 94070
Disclosure Statement: William Krimsky, MD is employed by Galvanize Therapeutics, Inc. Marcelo Jimenez and Jose Fernandez have not identified a conflict of interest.
ClinicalTrials.gov Identifier: NCT04732520
Funding Statement: Funding for the INCITE ES trial is provided to the Salamanca University Hospital by Galvanize Therapeutics, Inc.
EC Number and Date of Approval: C.E.I.M. reference 20/1615 (E.C.P.S.), approved January 22, 2021.
Informed Consent Statement: The patient was identified as an appropriate candidate and consented for study, standard of care procedures, and publication of the data for the Ethics Committee-approved INCITE ES trial (NCT04732520).
Corresponding Author Contact Information: William Krimsky, Galvanize Therapeutics, 1531 Industrial Rd, San Carlos, CA 94070
Article Word Count:750
Key Clinical Message: Hybrid ORs rarely support multiple specialties at once. We present a case where several specialties collaborated, mitigating non-diagnostic procedures when therapy relied on intraprocedural diagnosis.
Keywords: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Thoracic Surgical Procedures, Operating Rooms.
Glossary of Abbreviations: OR (operating room), NSCLC (non-small cell lung cancer), CT (computed tomography), RUL (right upper lobe), PET (positron emission tomography), SUV (standardized uptake value), PEF (pulsed electric field), CBCT (cone-beam computed tomography), PACU (post anesthesia care unit).